...
首页> 外文期刊>Journal of International Medical Research >An Open Study of Procaine Penicillin G, Clavulanate-Potentiated Amoxycillin and Probenecid in the Treatment of Acute Gonorrhoea
【24h】

An Open Study of Procaine Penicillin G, Clavulanate-Potentiated Amoxycillin and Probenecid in the Treatment of Acute Gonorrhoea

机译:普鲁卡因青霉素G,克拉维酸盐强化阿莫西林和丙磺舒治疗急性淋病的公开研究

获取原文

摘要

In an open study 55 patients presenting with acute gonorrhoea were given 4.8 mega units procaine penicillin G, intramuscularly, and oral probenecid (1 g) plus one 375-mg tablet clavulanate-potentiated amoxycillin orally. Before this treatment, 53 patients (96.4%) had presented with a purulent discharge, and dysuria was present in 47 patients (85.5%). The presence of Neisseria gonorrhoeae was confirmed by bacterial culture in 54 patients (98.2%). The majority of pathogens (92.5%) were penicillin resistant. On day 3 after treatment, dysuria was absent in 53 patients (96.4%) and there was no discharge in 40 cases (72.7%). N. gonorrhoeae was eradicated in 53 patients (96.4%). Two further patients were bacteriologically cured, but were suffering from post-gonococcal urethritis. The patients in whom discharge was still apparent were further assessed on day 7; discharge was resolved or resolving in all but one patient. There was one treatment failure. No adverse reactions were reported.
机译:在一项开放研究中,对55例急性淋病患者进行了4.8兆单位普鲁卡因青霉素G的肌内注射和口服丙磺舒(1 g)以及口服375毫克的克拉维酸加强型阿莫西林口服液。在该治疗之前,有53例患者(96.4%)出现化脓性分泌物,排尿困难的患者有47例(85.5%)。细菌培养证实淋病奈瑟氏菌存在于54名患者中(98.2%)。大多数病原体(92.5%)对青霉素耐药。治疗后第3天,有53例患者(96.4%)没有排尿困难,有40例(72.7%)没有排尿困难。淋病奈瑟菌根除53例(96.4%)。另外两名患者通过细菌学治愈,但患有淋球菌性尿道炎。在第7天进一步评估出院仍明显的患者;除一名患者外,其他所有患者的出院均已解决。有一个治疗失败。没有不良反应的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号